Cargando…
An immunoregulator nanomedicine approach for the treatment of tuberculosis
Introduction: A nanoparticle composed of a poly (lactic-co-glycolic acid) (PLGA) core and a chitosan (CS) shell with surface-adsorbed 1,3 β-glucan (β-glucan) was synthesized. The exposure response of CS-PLGA nanoparticles (0.1 mg/mL) with surface-bound β-glucan at 0, 5, 10, 15, 20, or 25 ng or free...
Autores principales: | Yang, Luona, Chaves, Lee, Kutscher, Hilliard L., Karki, Shanta, Tamblin, Maria, Kenney, Patrick, Reynolds, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249870/ https://www.ncbi.nlm.nih.gov/pubmed/37304141 http://dx.doi.org/10.3389/fbioe.2023.1095926 |
Ejemplares similares
-
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
por: Velino, Cecilia, et al.
Publicado: (2019) -
Bioclickable Mussel-Derived Peptides With Immunoregulation for Osseointegration of PEEK
por: Zhao, Huan, et al.
Publicado: (2021) -
A Methodological Safe-by-Design Approach for the Development of Nanomedicines
por: Schmutz, Mélanie, et al.
Publicado: (2020) -
Nanomedicine of Plant Origin for the Treatment of Metabolic Disorders
por: Hu, Fang, et al.
Publicado: (2022) -
Nanomedicines: A Potential Treatment for Blood Disorder Diseases
por: Zhang, Nan, et al.
Publicado: (2019)